Cargando…

Barriers and enablers to diabetic retinopathy screening: a cross-sectional survey of young adults with type 1 and type 2 diabetes in the UK

INTRODUCTION: Diabetic retinopathy screening (DRS) attendance in young adults (YAs) is consistently below recommended levels. The aim of this study was to identify barriers and enablers of DRS attendance among YAs in the UK living with type 1 (T1D) and type 2 diabetes (T2D). RESEARCH DESIGN AND METH...

Descripción completa

Detalles Bibliográficos
Autores principales: Prothero, Louise, Cartwright, Martin, Lorencatto, Fabiana, Burr, Jennifer M, Anderson, John, Gardner, Philip, Presseau, Justin, Ivers, Noah, Grimshaw, Jeremy M, Lawrenson, John G
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9685243/
https://www.ncbi.nlm.nih.gov/pubmed/36418058
http://dx.doi.org/10.1136/bmjdrc-2022-002971
_version_ 1784835460339597312
author Prothero, Louise
Cartwright, Martin
Lorencatto, Fabiana
Burr, Jennifer M
Anderson, John
Gardner, Philip
Presseau, Justin
Ivers, Noah
Grimshaw, Jeremy M
Lawrenson, John G
author_facet Prothero, Louise
Cartwright, Martin
Lorencatto, Fabiana
Burr, Jennifer M
Anderson, John
Gardner, Philip
Presseau, Justin
Ivers, Noah
Grimshaw, Jeremy M
Lawrenson, John G
author_sort Prothero, Louise
collection PubMed
description INTRODUCTION: Diabetic retinopathy screening (DRS) attendance in young adults (YAs) is consistently below recommended levels. The aim of this study was to identify barriers and enablers of DRS attendance among YAs in the UK living with type 1 (T1D) and type 2 diabetes (T2D). RESEARCH DESIGN AND METHODS: YAs (18–34 years) were invited to complete an anonymous online survey in June 2021 assessing agreement with 30 belief statements informed by the Theoretical Domains Framework (TDF) of behavior change describing potential barriers/enablers to DRS. RESULTS: In total, 102 responses were received. Most had T1D (65.7%) and were regular attenders for DRS (76.5%). The most salient TDF domains for DRS attendance were ‘Goals’, with 93% agreeing that DRS was a high priority, and ‘Knowledge’, with 98% being aware that screening can detect eye problems early. Overall, 67.4% indicated that they would like greater appointment flexibility (Environmental context/resources) and 31.3% reported difficulties getting time off work/study to attend appointments (Environmental context/resources). This was more commonly reported by occasional non-attenders versus regular attenders (59.1% vs 23.4%, p=0.002). Most YAs were worried about diabetic retinopathy (74.3%), anxious when receiving screening results (63%) (Emotion) and would like more support after getting their results (66%) (Social influences). Responses for T1D and T2D were broadly similar, although those with T2D were more likely have developed strategies to help them to remember their appointments (63.6% vs 37.9%, p=0.019) (Behavioral regulation). CONCLUSIONS: Attendance for DRS in YAs is influenced by complex interacting behavioral factors. Identifying modifiable determinants of behavior will provide a basis for designing tailored interventions to improve DRS in YAs and prevent avoidable vision loss.
format Online
Article
Text
id pubmed-9685243
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-96852432022-11-25 Barriers and enablers to diabetic retinopathy screening: a cross-sectional survey of young adults with type 1 and type 2 diabetes in the UK Prothero, Louise Cartwright, Martin Lorencatto, Fabiana Burr, Jennifer M Anderson, John Gardner, Philip Presseau, Justin Ivers, Noah Grimshaw, Jeremy M Lawrenson, John G BMJ Open Diabetes Res Care Epidemiology/Health services research INTRODUCTION: Diabetic retinopathy screening (DRS) attendance in young adults (YAs) is consistently below recommended levels. The aim of this study was to identify barriers and enablers of DRS attendance among YAs in the UK living with type 1 (T1D) and type 2 diabetes (T2D). RESEARCH DESIGN AND METHODS: YAs (18–34 years) were invited to complete an anonymous online survey in June 2021 assessing agreement with 30 belief statements informed by the Theoretical Domains Framework (TDF) of behavior change describing potential barriers/enablers to DRS. RESULTS: In total, 102 responses were received. Most had T1D (65.7%) and were regular attenders for DRS (76.5%). The most salient TDF domains for DRS attendance were ‘Goals’, with 93% agreeing that DRS was a high priority, and ‘Knowledge’, with 98% being aware that screening can detect eye problems early. Overall, 67.4% indicated that they would like greater appointment flexibility (Environmental context/resources) and 31.3% reported difficulties getting time off work/study to attend appointments (Environmental context/resources). This was more commonly reported by occasional non-attenders versus regular attenders (59.1% vs 23.4%, p=0.002). Most YAs were worried about diabetic retinopathy (74.3%), anxious when receiving screening results (63%) (Emotion) and would like more support after getting their results (66%) (Social influences). Responses for T1D and T2D were broadly similar, although those with T2D were more likely have developed strategies to help them to remember their appointments (63.6% vs 37.9%, p=0.019) (Behavioral regulation). CONCLUSIONS: Attendance for DRS in YAs is influenced by complex interacting behavioral factors. Identifying modifiable determinants of behavior will provide a basis for designing tailored interventions to improve DRS in YAs and prevent avoidable vision loss. BMJ Publishing Group 2022-11-23 /pmc/articles/PMC9685243/ /pubmed/36418058 http://dx.doi.org/10.1136/bmjdrc-2022-002971 Text en © Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Epidemiology/Health services research
Prothero, Louise
Cartwright, Martin
Lorencatto, Fabiana
Burr, Jennifer M
Anderson, John
Gardner, Philip
Presseau, Justin
Ivers, Noah
Grimshaw, Jeremy M
Lawrenson, John G
Barriers and enablers to diabetic retinopathy screening: a cross-sectional survey of young adults with type 1 and type 2 diabetes in the UK
title Barriers and enablers to diabetic retinopathy screening: a cross-sectional survey of young adults with type 1 and type 2 diabetes in the UK
title_full Barriers and enablers to diabetic retinopathy screening: a cross-sectional survey of young adults with type 1 and type 2 diabetes in the UK
title_fullStr Barriers and enablers to diabetic retinopathy screening: a cross-sectional survey of young adults with type 1 and type 2 diabetes in the UK
title_full_unstemmed Barriers and enablers to diabetic retinopathy screening: a cross-sectional survey of young adults with type 1 and type 2 diabetes in the UK
title_short Barriers and enablers to diabetic retinopathy screening: a cross-sectional survey of young adults with type 1 and type 2 diabetes in the UK
title_sort barriers and enablers to diabetic retinopathy screening: a cross-sectional survey of young adults with type 1 and type 2 diabetes in the uk
topic Epidemiology/Health services research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9685243/
https://www.ncbi.nlm.nih.gov/pubmed/36418058
http://dx.doi.org/10.1136/bmjdrc-2022-002971
work_keys_str_mv AT protherolouise barriersandenablerstodiabeticretinopathyscreeningacrosssectionalsurveyofyoungadultswithtype1andtype2diabetesintheuk
AT cartwrightmartin barriersandenablerstodiabeticretinopathyscreeningacrosssectionalsurveyofyoungadultswithtype1andtype2diabetesintheuk
AT lorencattofabiana barriersandenablerstodiabeticretinopathyscreeningacrosssectionalsurveyofyoungadultswithtype1andtype2diabetesintheuk
AT burrjenniferm barriersandenablerstodiabeticretinopathyscreeningacrosssectionalsurveyofyoungadultswithtype1andtype2diabetesintheuk
AT andersonjohn barriersandenablerstodiabeticretinopathyscreeningacrosssectionalsurveyofyoungadultswithtype1andtype2diabetesintheuk
AT gardnerphilip barriersandenablerstodiabeticretinopathyscreeningacrosssectionalsurveyofyoungadultswithtype1andtype2diabetesintheuk
AT presseaujustin barriersandenablerstodiabeticretinopathyscreeningacrosssectionalsurveyofyoungadultswithtype1andtype2diabetesintheuk
AT iversnoah barriersandenablerstodiabeticretinopathyscreeningacrosssectionalsurveyofyoungadultswithtype1andtype2diabetesintheuk
AT grimshawjeremym barriersandenablerstodiabeticretinopathyscreeningacrosssectionalsurveyofyoungadultswithtype1andtype2diabetesintheuk
AT lawrensonjohng barriersandenablerstodiabeticretinopathyscreeningacrosssectionalsurveyofyoungadultswithtype1andtype2diabetesintheuk
AT barriersandenablerstodiabeticretinopathyscreeningacrosssectionalsurveyofyoungadultswithtype1andtype2diabetesintheuk